Clinical Trial to Evaluate the Safety of PT150 (Formerly ORG34517) When it is Taken Concurrently With Alcohol
Status:
Completed
Trial end date:
2019-07-15
Target enrollment:
Participant gender:
Summary
The purpose of the clinical study is to compare pharmacodynamic and safety endpoints
following an alcohol challenge prior to and concurrent with PT150 (study drug) treatment.
Phase:
Phase 1
Details
Lead Sponsor:
Pop Test Oncology LLC
Collaborators:
Baylor College of Medical Center Baylor College of Medicine Congressionally Directed Medical Research Programs Congressionally Director Medical Research Programs Michael Debakey Veterans Affairs Medical Center Michael E. DeBakey VA Medical Center Pharmacotherapies for Alcohol and Substance Abuse Consortium University of California, San Diego